Literature DB >> 26017534

Triptan use among hospital workers affected by migraine.

G Viticchi1, L Falsetti, L Buratti, A Plutino, L Provinciali, M Silvestrini, M Bartolini.   

Abstract

Triptans represent the most specific and effective treatment for migraine attacks. Nevertheless, in clinical practice, they are often underused. Hospital workers, in particular physicians, are expected to be more aware of the correct use of specific drugs, especially for a very common disease such as migraine. Aim of this study was to evaluate whether different hospital workers affected by migraine are able to correctly manage the most suitable therapy for their migraine attacks. During a 1-year period, we submitted hospital employees to a structured interview with a questionnaire to investigate the presence of headache and its characteristics. In particular, in the subpopulation of subjects affected by migraine, we took information regarding their usual treatment for the control of attacks. The type of drug and the category of the working activity were synthesized as two different ordinal variables. Difference in the distribution of the different drug categories was evaluated with Chi squared test. Statistics was performed with SPSS 13.0 for Windows systems. We enrolled 1250 consecutive subjects: 20.3 % of the population (254 patients) was affected by migraine. Triptans use was significantly lower than that of non-steroidal anti-inflammatory drugs. The distribution of the use of the drugs was significantly different (p < 0.0001) at Chi squared test. Among migraineur physicians, only 10.7 % used triptans. Even in this subgroup, we observed a significant difference (p < 0.0001) in the distribution of the use of the drugs at Chi squared test. Our findings show a reduced use of triptans among hospital workers. These data reflect the unsatisfactory dissemination of knowledge regarding the correct management of migraine attacks and the advantages of treatment with triptans. An incorrect therapeutic approach to migraine contributes to the risk of the most important complications, such as drugs abuse or illness chronicization. These findings suggest that an insufficient awareness of migraine-related therapeutic options also involves hospital workers, including physicians.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26017534     DOI: 10.1007/s10072-015-2143-z

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  9 in total

Review 1.  Diagnostic accuracy of the ID Migraine: a systematic review and meta-analysis.

Authors:  Gráinne Cousins; Samira Hijazze; Floris A Van de Laar; Tom Fahey
Journal:  Headache       Date:  2011-06-07       Impact factor: 5.887

2.  The role of instrumental examinations in delayed migraine diagnosis.

Authors:  G Viticchi; M Silvestrini; L Falsetti; C Lanciotti; R Cerqua; S Luzzi; L Provinciali; M Bartolini
Journal:  Neurol Sci       Date:  2011-05       Impact factor: 3.307

3.  Time delay from onset to diagnosis of migraine.

Authors:  Giovanna Viticchi; Mauro Silvestrini; Lorenzo Falsetti; Chiara Lanciotti; Raffaella Cerqua; Simona Luzzi; Leandro Provinciali; Marco Bartolini
Journal:  Headache       Date:  2010-10-14       Impact factor: 5.887

Review 4.  The acute treatment of migraine in adults: the american headache society evidence assessment of migraine pharmacotherapies.

Authors:  Michael J Marmura; Stephen D Silberstein; Todd J Schwedt
Journal:  Headache       Date:  2015-01       Impact factor: 5.887

5.  Migraine prevalence and treatment patterns: the global Migraine and Zolmitriptan Evaluation survey.

Authors:  E Anne MacGregor; Jan Brandes; Astrid Eikermann
Journal:  Headache       Date:  2003-01       Impact factor: 5.887

6.  Triptans: low utilization and high turnover in the general population.

Authors:  A Panconesi; E Pavone; M Franchini; N Mennuti; Ml Bartolozzi; L Guidi; R Banfi
Journal:  Cephalalgia       Date:  2010-02-11       Impact factor: 6.292

7.  Diagnostic delay in migraine with aura.

Authors:  G Viticchi; M Bartolini; L Falsetti; J Dolcini; S Luzzi; L Provinciali; M Silvestrini
Journal:  Neurol Sci       Date:  2013-05       Impact factor: 3.307

8.  Triptans in the Italian population: a drug utilization study and a literature review.

Authors:  Alessandro Panconesi; Eleonora Pavone; Franca Vacca; Monica Vaiani; Roberto Banfi
Journal:  J Headache Pain       Date:  2008-03-04       Impact factor: 7.277

9.  Antimigraine medication use and associated health care costs in employed patients.

Authors:  Jun Wu; Mary D Hughes; Matthew F Hudson; Peggy J Wagner
Journal:  J Headache Pain       Date:  2011-11-30       Impact factor: 7.277

  9 in total
  3 in total

1.  Advances in clinical neurology through the journal "Neurological Sciences" (2015-2016).

Authors:  Ilaria Di Donato; Antonio Federico
Journal:  Neurol Sci       Date:  2017-01       Impact factor: 3.307

2.  O040. Migraineurs and self-consciousness of illness in a population of hospital workers.

Authors:  Giovanna Viticchi; Lorenzo Falsetti; Laura Buratti; Andrea Plutino; Leandro Provinciali; Mauro Silvestrini; Marco Bartolini
Journal:  J Headache Pain       Date:  2015-12       Impact factor: 7.277

3.  Migraine: incorrect self-management for a disabling disease.

Authors:  Giovanna Viticchi; Lorenzo Falsetti; Marco Bartolini; Laura Buratti; Alfio Ulissi; Maurizio Baldassari; Leandro Provinciali; Mauro Silvestrini
Journal:  Neurol Int       Date:  2018-04-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.